Phillip Monk
Chief Tech/Sci/R&D Officer bei SYNAIRGEN PLC
Vermögen: 27 284 $ am 31.03.2024
Profil
Phillip David Monk is currently the Executive Director & Chief Scientific Officer at Synairgen Plc since 2009.
He is also currently a Director at Synairgen Research Ltd.
Additionally, he previously worked as the Director-Respiratory & Inflammation Biology Group at MedImmune Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SYNAIRGEN PLC
0,21% | 31.12.2022 | 423 934 ( 0,21% ) | 27 284 $ | 31.03.2024 |
Aktive Positionen von Phillip Monk
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNAIRGEN PLC | Chief Tech/Sci/R&D Officer | 03.09.2009 |
Synairgen Research Ltd.
 Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The private company is based in Southampton, UK. Synairgen Research was founded in 2003. | Director/Board Member | 03.09.2009 |
Ehemalige bekannte Positionen von Phillip Monk
| Unternehmen | Position | Ende |
|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The private company is based in Southampton, UK. Synairgen Research was founded in 2003. | Commercial Services |
